--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About CORT20260220P35
Pharmaceutical
Corcept Therapeutics Incorporated was incorporated in Delaware on May 13, 1998. The company is a commercial stage company engaged in the discovery and development of drugs to treat serious endocrine, tumor, metabolic and neurological diseases by regulating the action of the hormone cortisol.
